Allogene Therapeutics
ALLO
ALLO
173 hedge funds and large institutions have $385M invested in Allogene Therapeutics in 2024 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 64 increasing their positions, 43 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
1.52% more ownership
Funds ownership: 77.6% → 79.12% (+1.5%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
34% less capital invested
Capital invested by funds: $586M → $385M (-$201M)
Holders
173
Holding in Top 10
2
Calls
$392K
Puts
$317K
Top Buyers
| 1 | +$20.3M | |
| 2 | +$20M | |
| 3 | +$17.4M | |
| 4 |
PA
Perceptive Advisors
New York
|
+$8.04M |
| 5 |
LCM
Lynx1 Capital Management
San Juan,
Puerto Rico
|
+$6.57M |
Top Sellers
| 1 | -$4.47M | |
| 2 | -$3.22M | |
| 3 | -$3.12M | |
| 4 |
ZIM
Zacks Investment Management
Chicago,
Illinois
|
-$2.06M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$1.97M |